Stuttgart - Delayed Quote EUR
Novo Nordisk A/S (NOVA.SG)
59.50
+0.90
+(1.54%)
As of 3:01:24 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
131,245,000
120,968,000
108,908,000
78,887,000
55,000,000
Investing Cash Flow
-139,524,000
-128,895,000
-43,892,000
-24,918,000
-31,605,000
Financing Cash Flow
40,568,000
8,735,000
-63,158,000
-51,797,000
-25,493,000
End Cash Position
38,613,000
15,655,000
14,392,000
12,653,000
10,719,000
Capital Expenditure
-56,886,000
-51,309,000
-38,896,000
-14,753,000
-7,385,000
Issuance of Debt
106,754,000
79,391,000
0
11,215,000
22,160,000
Repayment of Debt
-18,050,000
-6,335,000
-1,467,000
-13,623,000
-6,689,000
Repurchase of Capital Stock
-18,733,000
-20,181,000
-29,924,000
-24,086,000
-19,447,000
Free Cash Flow
74,359,000
69,659,000
70,012,000
64,134,000
47,615,000
12/31/2021 - 3/5/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GIKLY Grifols, S.A.
4.6500
0.00%
GIFOF Grifols, S.A.
8.25
0.00%
VIRP.PA Virbac SA
304.75
-1.02%
NOTA.F Novartis AG
93.60
-3.51%
REC.MI Recordati Industria Chimica e Farmaceutica S.p.A.
50.35
-2.71%
GRF.MC Grifols, S.A.
8.62
-3.51%
SAN.PA Sanofi
88.84
-0.97%
AZN.L AstraZeneca PLC
10,022.00
-1.55%
GSK.L GSK plc
1,360.00
+0.15%
LLY Eli Lilly and Company
714.52
-4.23%